NCT00398619View on ClinicalTrials.gov

A Study of the Effect of INCB013739 on Cortisone Reducing Enzyme Activity in Obese People Predisposed to Diabetes

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 2006

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
Insulin ResistanceObesity
Interventions
DRUG

INCB13739

Trial Locations (2)

90211

Beverly Hills

91911

Chula Vista

Sponsors

Lead Sponsor

Incyte Corporation
All Listed Sponsors
lead

Incyte Corporation

INDUSTRY